Solos Endoscopy, Inc. (OTCPINK: SNDY), a company that provides endoscopic Instrumentation and medical imaging solutions, announced, Thursday, November 7th, its new MammoView® Breast Cancer Global Initiative for 2014. The company plans to work with numerous breast cancer awareness campaigns year round to continue building upon the public’s ‘brand awareness’ for breast cancer; its detection, its treatment, and the need for a reliable, permanent cure.
Robert Segersten, President of Solos Endoscopy, stated in the company’s press release dated November 7th, “The MammoView® Breast Cancer Global Initiative is more than just awareness, it’s about education, and choices for women. October is over; people and businesses nationwide will take down their pink ribbons and pink signs, yet women all over the world will still be battling breast cancer. Solos Endoscopy will continue its efforts to fight breast cancer not just in October but throughout the year.”
Studies have shown that increased awareness has resulted in more women receiving mammograms, the number of breast cancers detected, and the number of women receiving biopsies. Management believes that as a result of increased awareness, breast cancers are being detected at an earlier, more treatable stage.
Solos Endoscopy’s new MammoView® Breast Cancer Global Initiative plans to team up with various foundations which are promoting Breast Cancer Awareness” and educate them about the clinical benefits of the MammoView® instrument line and breast ductoscopy. The entire MammoView® instrument line, with proper approval, is expected to begin being sold globally starting in 2014.
